Differentiate peptide classes and mechanisms
Understand receptor binding, gene expression modulation, and downstream signaling pathways across metabolic, growth hormone, and regenerative peptides.
Your patients are asking about peptides faster than most practices can get trained to answer. Build an evidence-based framework to evaluate, prescribe, and monitor peptide therapies across metabolic, growth hormone, and regenerative categories.
Regular price $595
$295
You save $300 through August 317-Day Money-Back Guarantee | 100% Online & Self-Paced | About 3 Hours to Complete
By the End of This Course, You Will Be Able To:
Understand receptor binding, gene expression modulation, and downstream signaling pathways across metabolic, growth hormone, and regenerative peptides.
Separate FDA-approved, compounded, and investigational products, including current 503A/503B sourcing rules and the status of AOD-9604, Melanotan II, and Epithalon.
Apply comprehensive history, contraindications, IGF-1 interpretation, and a monitoring schedule tied to each therapy.
Differentiate semaglutide, tirzepatide, and liraglutide by mechanism, labeled indication, and administration pattern.
Use standards built for compounded and investigational peptides, including WADA restrictions where relevant.
Implement sourcing verification, cash-pay economics, and FDA/FTC-compliant marketing.
Why This Course
Peptide therapy is expanding faster than most providers received formal training for it. Patients are arriving with information from social media and direct-to-consumer marketing — often without the clinical context to separate an FDA-approved therapy from a research-use-only compound being sold online. This course closes that gap with a structured, evidence-based curriculum instead of a protocol list.
What’s Included in the Course
Not dosing charts alone. Each module builds the knowledge, context, and practice framework needed to evaluate peptide therapies responsibly.
What peptides are, mechanisms of action, pharmacokinetics and half-life, routes of administration, and the three regulatory categories every provider needs to recognize: FDA-approved, compounded, and investigational/unapproved. Includes a full clinical case study walking through patient evaluation before initiating therapy.
GLP-1 and dual GIP/GLP-1 receptor agonism explained at the mechanism level, then applied product by product: semaglutide, tirzepatide, and liraglutide — indication, route, and dosing pattern differentiated so you’re not treating them as interchangeable. Covers pre-treatment evaluation, tolerability, follow-up, and the AOD-9604 investigational pipeline. Includes a dedicated section on current GLP-1 compounding rules under 503A and 503B following the resolution of national shortages.
Physiology of the growth hormone axis, then an agent-by-agent review: sermorelin, tesamorelin, CJC-1295 with and without DAC, ipamorelin, MK-677/ibutamoren, and GHRP-2/GHRP-6. Covers the CJC-1295 + ipamorelin combination, dosing and cycling considerations, IGF-1 interpretation, and a monitoring schedule for ongoing therapy.
BPC-157 (oral vs. injectable, proposed mechanisms, current evidence and regulatory status), the BPC-157 + TB-500 combination, and GHK-Cu — including where gut-healing and regenerative claims outpace the current evidence base.
503A/503B sourcing verification, recognizing RUO and gray-market red flags, consultation pricing and cash-pay models, FDA/FTC-compliant marketing, drug-drug interactions, adverse event reporting, and informed consent requirements built specifically for peptide therapy.
A peptide-by-peptide regulatory reference, current GLP-1 compounding updates, and PCAC classification changes — built as a resource you return to, not just a one-time read.
Key clinical takeaways and a consolidated educational disclaimer for your records.
Is This Course Right for You?
This course is designed to help the right providers move from patient questions to a structured clinical framework, while being clear about what self-paced education can and cannot provide.
This Course Is For
A strong fit for clinicians evaluating whether peptide therapy belongs in a metabolic, regenerative, or wellness-focused practice.
Set Expectations Before You Enroll
This is evidence-based, self-paced education. It gives you a framework for clinical decision-making; it does not remove professional responsibility.
Course Details
Faculty
Course content was developed for healthcare professionals evaluating peptide therapy across endocrinology, obesity medicine, regenerative medicine, sports medicine, and aesthetic practice, with emphasis on evidence-based clinical decision-making, responsible prescribing, and regulatory compliance.
Faculty bio / credentials — confirm before publishing.
Frequently Asked Questions
Ready to Get Started?
Get the clinical context, regulatory perspective, and ongoing reference tools to answer patient questions with greater clarity.
Enroll Now — $295 →This educational activity is intended solely for educational purposes and should not be interpreted as medical, legal, regulatory, or prescribing advice. Healthcare providers remain responsible for exercising independent clinical judgment and complying with all applicable regulations, standards of care, and professional requirements. Regulatory classifications for peptides are actively evolving; always verify current FDA guidance before prescribing.